# OnCo record nct07602777 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct07602777/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct07602777", "NCT07602777" ;
  schema:name "A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)"@en ;
  schema:description "A phase 1/2 trial of Ris-Rez in sarcomas, run by GlaxoSmithKline, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct07602777/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT07602777> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2026-06-22" ;
  onco:cancers <https://onco.cc/cancers/sarcoma/> ;
  onco:companies <https://onco.cc/companies/gsk/> .